Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1941 1
1946 1
1947 1
1949 1
1950 2
1952 2
1953 1
1955 2
1956 1
1957 1
1960 1
1962 2
1963 2
1964 2
1965 1
1967 3
1971 1
1972 5
1974 1
1975 1
1976 1
1977 2
1978 6
1979 2
1980 3
1981 1
1982 4
1983 2
1984 4
1985 2
1986 3
1988 1
1989 2
1990 1
1991 1
1992 1
1993 1
1994 2
1995 2
1997 1
2001 2
2002 1
2003 3
2004 1
2005 2
2006 2
2007 5
2008 7
2009 8
2010 6
2011 8
2012 3
2013 12
2014 12
2015 11
2016 13
2017 13
2018 13
2019 15
2020 14
2021 11
2022 12
2023 11
2024 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

242 results

Results by year

Filters applied: . Clear all
Page 1
Guideline of guidelines: urinary incontinence in women.
Sussman RD, Syan R, Brucker BM. Sussman RD, et al. BJU Int. 2020 May;125(5):638-655. doi: 10.1111/bju.14927. Epub 2020 Mar 8. BJU Int. 2020. PMID: 31625673 Review. No abstract available.
Benralizumab for the Prevention of COPD Exacerbations.
Criner GJ, Celli BR, Brightling CE, Agusti A, Papi A, Singh D, Sin DD, Vogelmeier CF, Sciurba FC, Bafadhel M, Backer V, Kato M, Ramírez-Venegas A, Wei YF, Bjermer L, Shih VH, Jison M, O'Quinn S, Makulova N, Newbold P, Goldman M, Martin UJ; GALATHEA Study Investigators; TERRANOVA Study Investigators. Criner GJ, et al. N Engl J Med. 2019 Sep 12;381(11):1023-1034. doi: 10.1056/NEJMoa1905248. Epub 2019 May 20. N Engl J Med. 2019. PMID: 31112385 Clinical Trial.
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, Lederer DJ, Nathan SD, Pereira CA, Sahn SA, Sussman R, Swigris JJ, Noble PW; ASCEND Study Group. King TE Jr, et al. Among authors: sussman r. N Engl J Med. 2014 May 29;370(22):2083-92. doi: 10.1056/NEJMoa1402582. Epub 2014 May 18. N Engl J Med. 2014. PMID: 24836312 Free article. Clinical Trial.
Reply by Authors.
Houston CG, Azar WS, Huang SS, Rubin R, Dorris CS, Sussman RD. Houston CG, et al. Among authors: sussman rd. Urol Pract. 2024 Mar;11(2):266. doi: 10.1097/UPJ.0000000000000513.03. Epub 2024 Jan 10. Urol Pract. 2024. PMID: 38214950 No abstract available.
Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical Trials.
Maher TM, Ford P, Brown KK, Costabel U, Cottin V, Danoff SK, Groenveld I, Helmer E, Jenkins RG, Milner J, Molenberghs G, Penninckx B, Randall MJ, Van Den Blink B, Fieuw A, Vandenrijn C, Rocak S, Seghers I, Shao L, Taneja A, Jentsch G, Watkins TR, Wuyts WA, Kreuter M, Verbruggen N, Prasad N, Wijsenbeek MS; ISABELA 1 and 2 Investigators. Maher TM, et al. JAMA. 2023 May 9;329(18):1567-1578. doi: 10.1001/jama.2023.5355. JAMA. 2023. PMID: 37159034 Free PMC article.
Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial.
Raghu G, Behr J, Brown KK, Egan JJ, Kawut SM, Flaherty KR, Martinez FJ, Nathan SD, Wells AU, Collard HR, Costabel U, Richeldi L, de Andrade J, Khalil N, Morrison LD, Lederer DJ, Shao L, Li X, Pedersen PS, Montgomery AB, Chien JW, O'Riordan TG; ARTEMIS-IPF Investigators*. Raghu G, et al. Ann Intern Med. 2013 May 7;158(9):641-9. doi: 10.7326/0003-4819-158-9-201305070-00003. Ann Intern Med. 2013. PMID: 23648946 Clinical Trial.
Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy.
Sotillo E, Barrett DM, Black KL, Bagashev A, Oldridge D, Wu G, Sussman R, Lanauze C, Ruella M, Gazzara MR, Martinez NM, Harrington CT, Chung EY, Perazzelli J, Hofmann TJ, Maude SL, Raman P, Barrera A, Gill S, Lacey SF, Melenhorst JJ, Allman D, Jacoby E, Fry T, Mackall C, Barash Y, Lynch KW, Maris JM, Grupp SA, Thomas-Tikhonenko A. Sotillo E, et al. Among authors: sussman r. Cancer Discov. 2015 Dec;5(12):1282-95. doi: 10.1158/2159-8290.CD-15-1020. Epub 2015 Oct 29. Cancer Discov. 2015. PMID: 26516065 Free PMC article.
Gaiha et al. Response.
Rich JJ, Sussman RA. Rich JJ, et al. Among authors: sussman ra. J Adolesc Health. 2021 Jan;68(1):215-216. doi: 10.1016/j.jadohealth.2020.09.014. J Adolesc Health. 2021. PMID: 33349355 No abstract available.
Rethinking primate origins again.
Sussman RW, Tab Rasmussen D, Raven PH. Sussman RW, et al. Am J Primatol. 2013 Feb;75(2):95-106. doi: 10.1002/ajp.22096. Epub 2012 Nov 26. Am J Primatol. 2013. PMID: 23184701 Review.
242 results